Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Leukemia & Lymphoma|February 26, 2008
The potential of histone deacetylase inhibitors for the treatment of multiple myelomaH Miles Prince, Mark Bishton, Simon Harrison
Clinical Lymphoma, Myeloma & Leukemia|June 19, 2013
A single-arm, phase II study of the anti-Blys monoclonal antibody belimumab in symptomatic Waldenstrom macroglobulinemiaMark Bishton, Andrew Spencer, Michael Dickinson, et al.
Expert Review of Anticancer Therapy|March 28, 2008
Histone deacetylase inhibitors in lymphoma and solid malignanciesWalid Rasheed, Mark Bishton, Ricky W Johnstone, et al.
British Journal of Haematology|March 11, 2021
The diagnostic and therapeutic challenges of Grade 3B follicular lymphomaAllison Barraclough, Mark Bishton, Chan Y Cheah, et al.
Expert Review of Anticancer Therapy|October 20, 2007
Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agentsMark Bishton, Melita Kenealy, Ricky Johnstone, et al.
Blood Advances|July 18, 2024
Impact of patient demographics on treatment outcomes in AML: a population-based registry in England, 2013-2020Hanhua Liu, Simon J Stanworth, Sean McPhail, et al.
BMC Medical Research Methodology|May 3, 2025
The REFRACT trial: implementation of Bayesian power priors in a randomised, sequential phase II adaptive platform trialCharlotte Gaskell, Kim Linton, Mark Bishton, et al.
Journal of Hematology & Oncology|May 26, 2023
1-year survival in haemophagocytic lymphohistiocytosis: a nationwide cohort study from England 2003-2018Joe West, Peter Stilwell, Hanhua Liu, et al.
Epigenomics|November 8, 2012
A focus on the preclinical development and clinical status of the histone deacetylase inhibitor, romidepsin (depsipeptide, Istodax(®))Simon J Harrison, Mark Bishton, Susan E Bates, et al.
The Lancet. Rheumatology|December 1, 2025
Trends in mortality due to haemophagocytic lymphohistiocytosis across 29 European countries from 2011 to 2021: a retrospective, international, population-based studyLeher Gumber, Reza Omidvar, Francesca Gonnelli, et al.
Pageof 4